Combination therapies targeting PD-1, TIM-3, and LAG-3 Grant US-11939380-B2 United States of America 26 Mar 2024
LAG-3-BINDING MOLECULKES AND METHODS OF USE THEREOF Application EP-4303235-A3 European Patent Office 13 Mar 2024